To advance urologic care through computational and functional genomics:
– Deciphering mechanisms of response and resistance to therapy
– Establishing new models to define gene function and cell phenotypes
– Fostering a new generation of computational urologists
We are looking forward to growing our lab and community. If you want to learn more about our work, please reach out to us!
01.24.2024 Kate selected to present her single cell work at American Association for Cancer Research (AACR) Annual Meeting
01.19.2024 Filipe is the 2023 awardee of the BCAN Bladder Cancer Career Development Award
12.19.2023 Chris’s work selected for presentation at European Association of Urology Annual meeting in Paris
11.06.2023 Filipe promoted to Assistant Professor of Surgery, Harvard Medical School
05.31.2023 Konrad’s work presented at ASCO Annual Meeting
04.20.2023 Welcome Kate!
For #trialtuesday, #CCTI_DFCI presents new trial 23-600 led by @FilipaLynce. IDE161, a PARG inhibitor, targets HRD and BRCA mutations in ER+ breast, endometrial, colorectal, and head and neck with these mutations. Different from PARPi. @DanaFarber
Visit: https://forms.office.com/r/kM7e6JVxre
📢 BCAN's Young Investigator & Patient-Centered Clinical Research Awards are now open! Act fast – deadline 2/22/24. Secure $75,000 funding for one year. Click for details and apply: https://bit.ly/48wba6I #ResearchFunding
Congratulations to @CarvalhoFilipeL of @BWHUrology, the recipient of BCAN's 2023 Career Development Award. Dr. De Carvalho's project will study overcoming resistance to chemo and IO in patients with MIBC .Click to read more: https://bcan.org/awardee-of-2023-bladder-cancer-career-development-award/